<?xml version="1.0" encoding="UTF-8"?>
<ref id="B87" class="ref">
 <div publication-type="journal" class="mixed-citation" xmlns="http://www.w3.org/1999/xhtml">
  <person-group person-group-type="author" class="person-group" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Van der Stoep</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">N.</span>
   </name>
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Quinten</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">E.</span>
   </name>
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Marcondes Rezende</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">M.</span>
   </name>
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Van den Elsen</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">P. J.</span>
   </name>
  </person-group> (
  <span class="year">2004</span>). 
  <div class="article-title">E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII)</div>. 
  <div class="source">Blood</div>
  <span class="volume">104</span>, 
  <span class="fpage">2849</span>â€“
  <span class="lpage">2857</span>
  <span pub-id-type="doi" class="pub-id">10.1182/blood-2004-03-0790</span>
  <span pub-id-type="pmid" class="pub-id">15242870</span>
 </div>
</ref>
